ARS Pharmaceuticals, Inc. Common Stock
Symbol: SPRY (NASDAQ)
9.85
▼ (-0.52%) -0.051
Company Description:
ARS Pharmaceuticals Inc is a biopharmaceutical company focused on the development of novel, potentially first-in-class product candidate, neffy for the emergency treatment of Type I allergic reactions, including anaphylaxis. neffy is a proprietary composition of epinephrine with an absorption enhancer called Intravail, which allows neffy to provide injection-like absorption of epinephrine at a low dose, in a small, easy-to-carry, easy-to-use, rapidly administered and reliable nasal spray.
Key Stats
- Today's Open: $9.86
- Today's High: $9.999
- Today's Low: $9.648
- Today's Volume: 1.17M
- Yesterday Close: $9.9
- Yesterday High: $10.1
- Yesterday Low: $9.665
- Yesterday Volume: 1.73M
- Last Min Volume: 0
- Last Min High: $9.849
- Last Min Low: $9.767
- Last Min VWAP: $0
Company Profile
- Name: ARS Pharmaceuticals, Inc. Common Stock
- Website: https://www.ars-pharma.com
- Listed Date: 2022-11-09
- Location: SAN DIEGO, CA
- Market Status: Active
- CIK Number: 0001671858
- SIC Code: 2834
- SIC description: PHARMACEUTICAL PREPARATIONS
- Market Cap: $978.38M
- Round Lot: 100
- Outstanding Shares: 98.83M
- Asset Type: CS
RECENT FILINGS FOR SPRY
| Filing Date | Filing Type | Format |
|---|---|---|
| 2025-10-01 | SCHEDULE 13D/A | View |
| 2025-09-29 | 8-K | View |
| 2025-08-28 | 8-K | View |
| 2025-08-22 | 4 | View |
| 2025-08-22 | 4 | View |
| 2025-08-21 | 4 | View |
| 2025-08-21 | 144 | View |
| 2025-08-21 | 144 | View |
| 2025-08-19 | 144 | View |
| 2025-08-13 | 10-Q | View |
| 2025-08-13 | 8-K | View |
| 2025-08-01 | SCHEDULE 13D/A | View |
| 2025-07-22 | SCHEDULE 13D/A | View |
| 2025-07-03 | 4 | View |
| 2025-07-02 | SCHEDULE 13D/A | View |
| 2025-07-01 | 4 | View |
| 2025-07-01 | 144 | View |
| 2025-06-27 | 4 | View |
| 2025-06-27 | 4 | View |
| 2025-06-27 | 4 | View |
Latest News on SPRY